AzTrials
AzTrials

Facial DiscriminationNCT03832101

Improvement of Facial Recognition Ability and Multitasking

A study testing MATB in people with Facial Discrimination and Multitasking, run by National University of Singapore at 1 site in Singapore.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to determine the efficacy of training on facial recognition and multitasking. The researchers hypothesize that participants who have undergone facial recognition and multitasking training will demonstrate an improved facial recognition ability and performance in multi-tasking. Read more about this study

Who is it for?
Ages 21 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Facial Discrimination, Multitasking
What is being tested?
MATB
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteSingapore
Study dates
13 Feb 2018to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Participants must be over 21 if they are not from NUS or Yale-NUS. NUS or Yale-NUS students over 18 can also participate. All participants are expected to be fluent in English.

Who cannot join

  • Participants with a history of perceptual or memory deficit will be excluded.

Trial locations and contacts

1 site in 1 country.

Christopher L Asplund, Ph.D. contact

+65660 3327

chris.asplund@yale-nus.edu.sg

Singapore1 site, 1 recruiting
  • National University of Singapore

    Singapore

    Christopher L Asplund, Ph.D., +6566013327, chris.asplund@yale-nus.edu.sg

    Recruiting

Other trials in Singapore

About this study

This study aims to determine the efficacy of training on facial recognition and multitasking. The researchers hypothesize that participants who have undergone facial recognition and multitasking training will demonstrate an improved facial recognition ability and performance in multi-tasking. The researchers also hypothesize that measures of sustained and selective attention will predict performance on multitasking tasks. This work sets the ground work for future research into if and how facial recognition and multitasking ability can be improved.

Read the detailed description

There has been evidence showing improvements on performance on various cognitive tasks after training, but evidence on multitasking and facial recognition is lacking. Both multi-tasking and facial recognition are crucial for military and law enforcement personnel, and the respective organizations can consider these abilities during their respective recruitment and training processes.

This study will test whether training on multi-tasking and facial recognition tasks can improve an individual's performance. Additionally, it will test whether their performance on other measures of attention and multitasking can predict changes post-training.

Participants will go through 5 testing sessions span over 5 days. For each session, participants will complete a multitasking task and a facial recognition task. Participants are hypothesized to improve in their performance after 5 consecutive days of training on these 2 tasks. Additionally, participants will also complete 2 attention tasks, 1 face memory task, and 1 other multi-tasking task only on the first day. Both multitasking tasks are expected to correlate at baseline, and performance on the attention tasks may predict performance on multitasking tasks as these tasks require sustained and selective attention. A face memory task will also be used to account for each individual's baseline facial recognition ability.

Being tested
MATB

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MATBBehavioural

    MATB has two multitasking tasks and two attention tasks. The two multitasking tasks evaluates performance on multiple cognitively demanding assignments in both the auditory and visual domains. The two attention tasks measures performance in sustained and selective attention

Study groups in NCT03832101
Study groupRoleWhat they receive
Difficult face discriminationExperimentalAll participants will complete 5 training and testing sessions in total, once a day, over the course of a week (weekdays). On the first day, participants will go through an initial test (Cambridge Face Memory Test; approximately 15 minutes) to determine their baseline facial recognition ability. Thereafter, participants in the Difficult group will undergo training involving discriminations between highly similar faces. Each participant's involvement in the study will last only 5 consecutive days. The total participation time is 7.5 hours per participant.
Receives: Behavioral: MATB
Easy face discriminationExperimentalAll participants will complete 5 training and testing sessions in total, once a day, over the course of a week (weekdays). On the first day, participants will go through an initial test (Cambridge Face Memory Test; approximately 15 minutes) to determine their baseline facial recognition ability. Those in the Easy group will discriminate between dissimilar faces. Each participant's involvement in the study will last only 5 consecutive days. The total participation time is 7.5 hours per participant.
Receives: Behavioral: MATB
ControlActive comparatorAll participants will complete 5 training and testing sessions in total, once a day, over the course of a week (weekdays). On the first day, participants will go through an initial test (Cambridge Face Memory Test; approximately 15 minutes) to determine their baseline facial recognition ability. Those in the Control group will perform a simple face-matching exercise. This training will last for approximately 30 minutes. Each participant's involvement in the study will last only 5 consecutive days. The total participation time is 7.5 hours per participant.
Receives: Behavioral: MATB

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Facial recognition performance change during training

    The crucial measure is percent correct recognition of target faces learned on the first day. These faces are either presented in isolation (Is this a target face? Yes/No) or with other faces (Which is the target?). Performance is measured on each day of training to establish learning trajectories.

    Measured: Day 1, 2, 3, 4, 5

  2. Multi-tasking performance change during training

    The crucial measures are speed and accuracy on each component task of the MATB (Multi-Attribute Task Battery; Comstock \& Arnegard, 1992). Performance is measured on each day of training to establish learning trajectories.

    Measured: Day 1, 2, 3, 4, 5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2019
  2. Study start13 Feb 2018
  3. Primary completionDec 2020 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03832101
Sponsor's protocol ID
S-17-180
Status last verified
Feb 2019
First submitted
2 Feb 2019
Last updated
6 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing MATB in people with Facial Discrimination and Multitasking, run by National University of Singapore at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christopher L Asplund, Ph.D. (+65660 3327, chris.asplund@yale-nus.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Facial recognition performance change during training (time frame: Day 1, 2, 3, 4, 5). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in